Development of novel fluorinated reagents for preparation of drugs.

Información del proyecto

FLUNOVELTY

Identificador del acuerdo de subvención: 654260

DOI 10.3030/654260

Proyecto cerrado

Fecha de la firma de la CE 26 Marzo 2015

Fecha de inicio 1 Noviembre 2015

Fecha de finalización 31 Octubre 2016

Financiado con arreglo a

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coste total € 92 538,00

Aportación de la UE € 92 538,00

Coordinado por

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS
France

Objetivo

Around 20% of all modern drugs are fluorinated organic molecules. During the recent years, however, pharmaceutical companies struggle to deliver novel drugs to the market, because of the lack of innovative practical reagents and reactions towards “drug-like” compounds.
In this project, we will address this issue by discovering novel small fluorinating reagents - fluorinated diazoalkanes, - elaborate their practical reactions, and use this knowledge to develop alternative synthetic approaches to some known drugs (AS-136A, Celecoxib).

Ámbito científico

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programa(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Tema(s)

• MSCA-IF-2014-EF - Marie Skłodowska-Curie Individual Fellowships (IF-EF)

Convocatoria de propuestas

H2020-MSCA-IF-2014

Régimen de financiación

MSCA-IF-EF-ST - Standard EF

Coordinador

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS

• Aportación neta de la UEn: € 92 538,00
• Dirección: RUE VAUQUELIN 10 ; 75231 Paris ; Francia
• Región: Ile-de-France › Ile-de-France › Paris
• Tipo de actividad: Higher or Secondary Education Establishments
• Coste total: € 92 538,00